Get the up-to-date 510(k) SUMMARY NOV 172010 1 - accessdata fda 2024 now

Get Form
510(k) SUMMARY NOV 172010 1 - accessdata fda Preview on Page 1

Here's how it works

01. Edit your form online
01. Edit your form online
Type text, add images, blackout confidential details, add comments, highlights and more.
02. Sign it in a few clicks
02. Sign it in a few clicks
Draw your signature, type it, upload its image, or use your mobile device as a signature pad.
03. Share your form with others
03. Share your form with others
Send it via email, link, or fax. You can also download it, export it or print it out.

The best way to edit 510(k) SUMMARY NOV 172010 1 - accessdata fda online

Form edit decoration
9.5
Ease of Setup
DocHub User Ratings on G2
9.0
Ease of Use
DocHub User Ratings on G2

With DocHub, making adjustments to your paperwork takes only a few simple clicks. Follow these quick steps to edit the PDF 510(k) SUMMARY NOV 172010 1 - accessdata fda online for free:

  1. Sign up and log in to your account. Log in to the editor with your credentials or click Create free account to evaluate the tool’s functionality.
  2. Add the 510(k) SUMMARY NOV 172010 1 - accessdata fda for editing. Click the New Document button above, then drag and drop the document to the upload area, import it from the cloud, or using a link.
  3. Modify your document. Make any adjustments needed: insert text and images to your 510(k) SUMMARY NOV 172010 1 - accessdata fda, underline details that matter, erase parts of content and replace them with new ones, and add symbols, checkmarks, and fields for filling out.
  4. Finish redacting the template. Save the updated document on your device, export it to the cloud, print it right from the editor, or share it with all the people involved.

Our editor is super easy to use and efficient. Try it out now!

be ready to get more

Complete this form in 5 minutes or less

Get form

Got questions?

We have answers to the most popular questions from our customers. If you can't find an answer to your question, please contact us.
Contact us
The FDA maintains a database of premarket notification 510(k) submissions on its official website, enabling users to search for existing submissions using criteria such as the 510(k) number, applicant, device name or FDA product code.
That means the summary document you created will be out there for everyone to see. Per CFR 21 Part 807.95(d), FDA will make a 510(k) summary of the safety and effectiveness data available to the public within 30 days of the issuance of a determination that the device is substantially equivalent to another device.
Device firms should also ensure that the 510(k) submission contains all the necessary documentation the FDA expects, including device labeling, instructions for use, and a detailed summary of the devices design and sterilization/shelf life and packaging processes, if applicable.
510(k) Decision Letter The FDA goal to make a MDUFA Decision for a 510(k) is 90 FDA Days. FDA Days are calculated as the number of calendar days between the date the 510(k) was received and the date of a MDUFA decision, excluding the days the submission was on hold for an AI request.
The 510(k) summary is similar, in that it is a brief summary of the device and the supporting information, while the 510(k) statement is a certification that the 510(k) holder will provide a copy of the submission to any FDA personnel within 30 days of a written request.

People also ask

A 510(k) requires demonstration of substantial equivalence to another legally U.S. marketed device. Substantial equivalence means that the new device is as safe and effective as the predicate. the information submitted to FDA demonstrates that the device is as safe and effective as the legally marketed device.
After all of this hard work, the last thing you want is to discover the FDA has rejected your application. Unfortunately, this is what happens to over 64% of 510(k) applications submitted for FDA clearance. Over 30% of these applications are not even accepted for initial review.
The 510(k) clearance process involves a comprehensive review of safety and performance data for the device, which may include scientific, non-clinical, and clinical data, as appropriate, to determine if a new device is substantially equivalent to a device that is already on the market (that is, a predicate device).

Related links